The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nayersina, R.
Right arrow Articles by Redeker, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nayersina, R.
Right arrow Articles by Redeker, A. G.

The Journal of Immunology, Vol 150, Issue 10 4659-4671, Copyright © 1993 by American Association of Immunologists


ARTICLES

HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection

R Nayersina, P Fowler, S Guilhot, G Missale, A Cerny, HJ Schlicht, A Vitiello, R Chesnut, JL Person and AG Redeker
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.

Inasmuch as the hepatitis B virus (HBV) is not directly cytopathic for the infected hepatocyte, it is generally presumed that viral clearance and liver cell injury during viral hepatitis are due to a CTL response to HBV encoded Ag presented by HLA class I molecules. We have previously examined the peripheral blood CTL response to two HBV nucleocapsid epitopes in patients with acute and chronic viral hepatitis, one of which is restricted by HLA-A2, whereas the other is dually restricted by HLA-A31 and Aw68. In this study, we defined the HLA-A2-restricted CTL response to the hepatitis B surface Ag (HBsAg) by using a panel of HBsAg-derived synthetic peptides containing the ideal HLA-A2.1 binding motif (-L------V). Several novel aspects of HBV immunobiology and pathogenesis are evident from this study. First, the peripheral blood CTL response to HBV-encoded Ag is remarkably polyclonal and multispecific in most patients with acute hepatitis. Indeed, HLA-A2-restricted CTL specific for as many as four envelope epitopes and one nucleocapsid epitope were found to be present simultaneously in individual patients with acute viral hepatitis. Second, HBV-specific CTL are not detectable in the peripheral blood in a minority of patients with acute hepatitis, nor have we detected a CTL response in any of the patients with chronic hepatitis that we have studied thus far. Although the cellular and molecular basis for CTL nonresponse remains to be determined, the data suggest that it may contribute to viral persistence. Third, the diversity and the specificity of the CTL response is determined in part by the coding sequence of the viral genome present in each infected patient. Indeed, the apparent nonresponse of some acutely infected patients to at least one HBsAg-specific CTL epitope actually reflects infection by a viral variant that contains a critical substitution in one of the anchor residues within the epitope. Finally, at a fundamental level, the data suggest that the presence of the HLA-A2.1-binding motif in a peptide may not be sufficient for binding; and the capacity of a peptide to bind the class I molecule does not guarantee that it will be immunogenic.


This article has been cited by other articles:


Home page
J. Virol.Home page
A. T. Tan, E. Loggi, C. Boni, A. Chia, A. J. Gehring, K. S. R. Sastry, V. Goh, P. Fisicaro, P. Andreone, C. Brander, et al.
Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire
J. Virol., November 15, 2008; 82(22): 10986 - 10997.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
R. J. Stoffels and H. G. Spencer
An Asymmetric Model of Heterozygote Advantage at Major Histocompatibility Complex Genes: Degenerate Pathogen Recognition and Intersection Advantage
Genetics, March 1, 2008; 178(3): 1473 - 1489.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Depla, A. Van der Aa, B. D. Livingston, C. Crimi, K. Allosery, V. De Brabandere, J. Krakover, S. Murthy, M. Huang, S. Power, et al.
Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections
J. Virol., January 1, 2008; 82(1): 435 - 450.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Mancini-Bourgine, F. Bayard, P. Soussan, Q. Deng, Y.-C. Lone, D. Kremsdorf, and M.-L. Michel
Hepatitis B Virus Splice-Generated Protein Induces T-Cell Responses in HLA-Transgenic Mice and Hepatitis B Virus-Infected Patients
J. Virol., May 15, 2007; 81(10): 4963 - 4972.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Boni, P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, et al.
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
J. Virol., April 15, 2007; 81(8): 4215 - 4225.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. D. Robek, M. L. Garcia, B. S. Boyd, and F. V. Chisari
Role of Immunoproteasome Catalytic Subunits in the Immune Response to Hepatitis B Virus
J. Virol., January 15, 2007; 81(2): 483 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Bertoletti and A. J. Gehring
The immune response during hepatitis B virus infection
J. Gen. Virol., June 1, 2006; 87(6): 1439 - 1449.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W.-P. Woo, T. Doan, K. A. Herd, H.-J. Netter, and R. W. Tindle
Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
J. Virol., April 1, 2006; 80(8): 3975 - 3984.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Riedl, A. Bertoletti, R. Lopes, F. Lemonnier, J. Reimann, and R. Schirmbeck
Distinct, Cross-Reactive Epitope Specificities of CD8 T Cell Responses Are Induced by Natural Hepatitis B Surface Antigen Variants of Different Hepatitis B Virus Genotypes
J. Immunol., April 1, 2006; 176(7): 4003 - 4011.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Murray, S. F. Wieland, R. H. Purcell, and F. V. Chisari
Dynamics of hepatitis B virus clearance in chimpanzees
PNAS, December 6, 2005; 102(49): 17780 - 17785.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. F. Wieland and F. V. Chisari
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses
J. Virol., August 1, 2005; 79(15): 9369 - 9380.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. F. Wieland, A. Eustaquio, C. Whitten-Bauer, B. Boyd, and F. V. Chisari
Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids
PNAS, July 12, 2005; 102(28): 9913 - 9917.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. L. Hutchings, S. C. Gilbert, A. V. S. Hill, and A. C. Moore
Novel Protein and Poxvirus-Based Vaccine Combinations for Simultaneous Induction of Humoral and Cell-Mediated Immunity
J. Immunol., July 1, 2005; 175(1): 599 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Mizukoshi, J. Sidney, B. Livingston, M. Ghany, J. H. Hoofnagle, A. Sette, and B. Rehermann
Cellular Immune Responses to the Hepatitis B Virus Polymerase
J. Immunol., November 1, 2004; 173(9): 5863 - 5871.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. J. M. Webster, S. Reignat, D. Brown, G. S. Ogg, L. Jones, S. L. Seneviratne, R. Williams, G. Dusheiko, and A. Bertoletti
Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy
J. Virol., June 1, 2004; 78(11): 5707 - 5719.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H.-C. Wang, H.-C. Wu, C.-F. Chen, N. Fausto, H.-Y. Lei, and I.-J. Su
Different Types of Ground Glass Hepatocytes in Chronic Hepatitis B Virus Infection Contain Specific Pre-S Mutants that May Induce Endoplasmic Reticulum Stress
Am. J. Pathol., December 1, 2003; 163(6): 2441 - 2449.
[Abstract] [Full Text]


Home page
GutHome page
T Imamura, O Yokosuka, T Kurihara, T Kanda, K Fukai, F Imazeki, and H Saisho
Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan
Gut, November 1, 2003; 52(11): 1630 - 1637.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. Loirat, M. Mancini-Bourgine, J.-P. Abastado, and M.-L. Michel
HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection
Int. Immunol., October 1, 2003; 15(10): 1125 - 1136.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Urbani, C. Boni, G. Missale, G. Elia, C. Cavallo, M. Massari, G. Raimondo, and C. Ferrari
Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C
J. Virol., November 13, 2002; 76(24): 12423 - 12434.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Kakimi, M. Isogawa, J. Chung, A. Sette, and F. V. Chisari
Immunogenicity and Tolerogenicity of Hepatitis B Virus Structural and Nonstructural Proteins: Implications for Immunotherapy of Persistent Viral Infections
J. Virol., July 29, 2002; 76(17): 8609 - 8620.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Alexander, C. Oseroff, C. Dahlberg, M. Qin, G. Ishioka, M. Beebe, J. Fikes, M. Newman, R. W. Chesnut, P. A. Morton, et al.
A Decaepitope Polypeptide Primes for Multiple CD8+ IFN-{gamma} and Th Lymphocyte Responses: Evaluation of Multiepitope Polypeptides as a Mode for Vaccine Delivery
J. Immunol., June 15, 2002; 168(12): 6189 - 6198.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Kita, Z.-X. Lian, J. Van de Water, X.-S. He, S. Matsumura, M. Kaplan, V. Luketic, R. L. Coppel, A. A. Ansari, and M. E. Gershwin
Identification of HLA-A2-restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis: T Cell Activation Is Augmented by Immune Complexes Cross-Presented by Dendritic Cells
J. Exp. Med., January 7, 2002; 195(1): 113 - 123.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Thimme, K.-M. Chang, J. Pemberton, A. Sette, and F. V. Chisari
Degenerate Immunogenicity of an HLA-A2-Restricted Hepatitis B Virus Nucleocapsid Cytotoxic T-Lymphocyte Epitope That Is Also Presented by HLA-B51
J. Virol., April 15, 2001; 75(8): 3984 - 3987.
[Abstract] [Full Text]


Home page
J. Virol.Home page
T. M. Allen, B. R. Mothé, J. Sidney, P. Jing, J. L. Dzuris, M. E. Liebl, T. U. Vogel, D. H. O'Connor, X. Wang, M. C. Wussow, et al.
CD8+ Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing
J. Virol., January 15, 2001; 75(2): 738 - 749.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. D. Sette, C. Oseroff, J. Sidney, J. Alexander, R. W. Chesnut, K. Kakimi, L. G. Guidotti, and F. V. Chisari
Overcoming T Cell Tolerance to the Hepatitis B Virus Surface Antigen in Hepatitis B Virus-Transgenic Mice
J. Immunol., January 15, 2001; 166(2): 1389 - 1397.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Loirat, F. A. Lemonnier, and M.-L. Michel
Multiepitopic HLA-A*0201-Restricted Immune Response Against Hepatitis B Surface Antigen After DNA-Based Immunization
J. Immunol., October 15, 2000; 165(8): 4748 - 4755.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S I Khakoo, R Ling, I Scott, A I Dodi, T J Harrison, G M Dusheiko, and J A Madrigal
Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals
Gut, July 1, 2000; 47(1): 137 - 143.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. I. Michalak, P. D. Hodgson, and N. D. Churchill
Posttranscriptional Inhibition of Class I Major Histocompatibility Complex Presentation on Hepatocytes and Lymphoid Cells in Chronic Woodchuck Hepatitis Virus Infection
J. Virol., May 15, 2000; 74(10): 4483 - 4494.
[Abstract] [Full Text]


Home page
JEMHome page
M. K. Maini, C. Boni, C. K. Lee, J. R. Larrubia, S. Reignat, G. S. Ogg, A. S. King, J. Herberg, R. Gilson, A. Alisa, et al.
The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection
J. Exp. Med., April 17, 2000; 191(8): 1269 - 1280.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. V. Chisari
Viruses, Immunity, and Cancer: Lessons from Hepatitis B
Am. J. Pathol., April 1, 2000; 156(4): 1117 - 1132.
[Full Text] [PDF]


Home page
JEMHome page
G. Lauvau, K. Kakimi, G. Niedermann, M. Ostankovitch, P. Yotnda, H. Firat, F. V. Chisari, and P. M. van Endert
Human Transporters Associated with Antigen Processing (Taps) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells
J. Exp. Med., November 1, 1999; 190(9): 1227 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Kimura, K. Ando, H. Ohnishi, T. Ishikawa, S. Kakumu, M. Takemura, Y. Muto, and H. Moriwaki
Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A
Int. Immunol., September 1, 1999; 11(9): 1491 - 1500.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Y. Ishioka, J. Fikes, G. Hermanson, B. Livingston, C. Crimi, M. Qin, M. France del Guercio, C. Oseroff, C. Dahlberg, J. Alexander, et al.
Utilization of MHC Class I Transgenic Mice for Development of Minigene DNA Vaccines Encoding Multiple HLA-Restricted CTL Epitopes
J. Immunol., April 1, 1999; 162(7): 3915 - 3925.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. D. Livingston, J. Alexander, C. Crimi, C. Oseroff, E. Celis, K. Daly, L. G. Guidotti, F. V. Chisari, J. Fikes, R. W. Chesnut, et al.
Altered Helper T Lymphocyte Function Associated with Chronic Hepatitis B Virus Infection and its Role in Response to Therapeutic Vaccination in Humans
J. Immunol., March 1, 1999; 162(5): 3088 - 3095.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K.-M. Chang, N. H. Gruener, S. Southwood, J. Sidney, G. R. Pape, F. V. Chisari, and A. Sette
Identification of HLA-A3 and -B7-Restricted CTL Response to Hepatitis C Virus in Patients with Acute and Chronic Hepatitis C
J. Immunol., January 15, 1999; 162(2): 1156 - 1164.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Lu, G. Hilken, J. Kruppenbacher, T. Kemper, R. Schirmbeck, J. Reimann, and M. Roggendorf
Immunization of Woodchucks with Plasmids Expressing Woodchuck Hepatitis Virus (WHV) Core Antigen and Surface Antigen Suppresses WHV Infection
J. Virol., January 1, 1999; 73(1): 281 - 289.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Ishikawa, D. Kono, J. Chung, P. Fowler, A. Theofilopoulos, S. Kakumu, and F. V. Chisari
Polyclonality and Multispecificity of the CTL Response to a Single Viral Epitope
J. Immunol., December 1, 1998; 161(11): 5842 - 5850.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Shimizu, L. G. Guidotti, P. Fowler, and F. V. Chisari
Dendritic Cell Immunization Breaks Cytotoxic T Lymphocyte Tolerance in Hepatitis B Virus Transgenic Mice
J. Immunol., November 1, 1998; 161(9): 4520 - 4529.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Bertoni, A. Sette, J. Sidney, L. G. Guidotti, M. Shapiro, R. Purcell, and F. V. Chisari
Human Class I Supertypes and CTL Repertoires Extend to Chimpanzees
J. Immunol., October 15, 1998; 161(8): 4447 - 4455.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Menne, J. Maschke, M. Lu, H. Grosse-Wilde, and M. Roggendorf
T-Cell Response to Woodchuck Hepatitis Virus (WHV) Antigens during Acute Self-Limited WHV Infection and Convalescence and after Viral Challenge
J. Virol., July 1, 1998; 72(7): 6083 - 6091.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.